Topic

Adenocarcinoma


CT Screening: Where Do We Stand?

Cover Story | Monday, June 21 2010
Written by C.P. Kaiser
Ten years ago, it was nearly impossible to go through the day without seeing an advertisement for whole-body CT screening. Today it’s a different story. The radiation dose exposure from CT scanning has come under intense scrutiny and the value of CT screening must be proved in rigorous trials before many payors, especially Medicare, will consider reimbursing for an exam.
 

ASCO: FAMT PET predicts prognosis of non-small cell lung cancer

Conference News | Tuesday, June 08 2010
[18F]-alpha-methyl tyrosine (18F-FAMT) PET is a potential prognostic marker in patients with pulmonary adenocarcinoma, according to a presentation made June 5 at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
 

Radiology: Polyp size is critical biomarker for CTC screening, diagnosis

Portal Exclusives | Thursday, June 03 2010
Until the development of biomarkers indicative of histology, polyp size will continue to be the most important biomarker for determining management of colonic polyps found at screening and diagnostic CT colonography (CTC), according to a review in this month’s Radiology.
 

Study: Radiation ineffective for rare bladder cancer cases

Conference News | Wednesday, June 02 2010
In observing various treatment modalities for primary adenocarcinoma of the bladder, researchers from Henry Ford Hospital in Detroit determined that radiation therapy may not improve a patient's chances for survival.
 

JNM: Dual-phase PET predicts prognosis in lung adenocarcinoma

Clinical Studies | Tuesday, March 30 2010
Dual-phase 18F-FDG PET with measurement of the percentage maximal standardized uptake values change may significantly affect the management of patients with lung adenocarcinoma and could be complementary to other well-known factors, according to a study published in the April issue of the Journal of Nuclear Medicine.
 

SIR: Image-guided nanoembolization - therapy for pancreatic ductal adenocarcinoma

Conference News | Tuesday, March 16 2010
A novel pancreas-directed local approach, using image-guided nanoembolization, increases intra-tumoral uptake of therapeutic gold nanoparticles over systemic IV administration in a rabbit model of pancreatic ductal adenocarcinoma (PDAC), according to a presentation at the Society of Interventional Radiology's (SIR) 35th annual scientific meeting in Tampa, Fla. this week.
 

MHNC: Proton beam therapy shows promise in advanced sinonasal cancers

Conference News | Tuesday, March 02 2010
Proton beam radiation therapy showed encouraging results for patients with locally advanced sinonasal malignancies, according to a study presented Feb.25 at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz.
 

RSNA: Peptides show promise in designing molecular ultrasound contrast agents

Conference News | Thursday, December 03 2009
Knottin peptides may be a promising platform for designing novel contrast agents for molecular ultrasound imaging of tumor angiogenesis, according to a study presented at the annual Radiological Society of North America (RSNA) meeting.
 

FMT-PET aids lung cancer predictive capabilities

Portal Exclusives | Tuesday, November 24 2009
Written by Editorial Staff
The uptake of the radiopharmaceutical fluoro methyl tyrosine (FMT) on PET imaging in patients with pulmonary adenocarcinoma is a significant independent predictor of poor prognosis, according to research published in this month’s issue of the Journal of Nuclear Medicine.
 

11C-choline prostate cancer imaging awaits next-generation technology

Portal Exclusives | Thursday, October 29 2009
The fusion of 11C-choline PET data with high-resolution anatomic imaging (such as future hybrid PET/MRI systems) may offer the potential to guide targeted prostate biopsies and to noninvasively select high-risk prostate cancer patients for definitive treatments such as surgery or radiotherapy, according to research published in the October issue of the Journal of Nuclear Medicine.
 

JNM: Combined tracers aid PET imaging for endometrial carcinoma

Clinical Studies | Thursday, October 01 2009
A PET scan with F18-fluoroestradiol may provide physicians with more information about endometrial carcinoma, according to research published in this month’s Journal of Nuclear Medicine.
 

RF ablation could reduce gastrointestinal cancer risk

Clinical Studies | Wednesday, May 27 2009
Radiofrequency (RF) ablation is an effective treatment for dysplasia in people with Barrett's esophagus, a condition that can lead to deadly gastrointestinal cancer, according to a study published in the May 28 issue of the New England Journal of Medicine.
 

CT screening may benefit lung cancer patients

Clinical Studies | Wednesday, May 13 2009
CT screening may be able to detect early stage lung cancers, and improve the prognosis of lung cancer patients, according to a retrospective study in the May issue of the Journal of Thoracic Oncology.
 
Web Exclusives

Feature: U.S. needs national strategy to curb imaging overutilization

Medical imaging overutilization--a growing concern in the U.S.--exposes patients to unnecessary radiation, while also adding to rising healthcare costs, according to a study published online Aug. 24 in Radiology. In an interview, William R. Hendee, PhD, lead author, reviewed various methods by which medical imaging could be curtailed.

Radiology: Prelim study shows CE breast CT outperforms CT, mammo

Dedicated contrast-enhanced (CE) breast CT delivered significantly improved conspicuity of malignant breast lesions, including ductal carcinoma in situ (DCIS), compared with unenhanced breast CT and mammography, according to a study published in the September issue of Radiology.

Radiology: Rad role may evolve as image-guided biopsies trend up

CT, ultrasound and MRI have helped shift biopsy techniques away from more invasive approaches toward image-guided percutaneous techniques, according to a study published in the September issue of Radiology. The trend toward less-invasive approaches translates into enhanced safety and efficiency and could lead to more interaction between patients and radiologists.

CMS Webinar: Incentive payments to offset EHR adoption, not reimburse

The Centers for Medicare & Medicaid Services’ (CMS) EHR incentive payments are not considered reimbursement for money expended on EHR technology, but are intended to offset the cost associated with adoption and ongoing meaningful use, according to CMS during an Aug. 12 webinar.

CMS webinar: Eligible professionals can expect EHR incentives in 2011

Funding incentives for EHR use is the main goal of the Centers for Medicare & Medicaid Services' (CMS) meaningful use initiative, and there are incentive programs for both hospitals and eligible professionals, according to Elizabeth Holland, health insurance specialist at the Department of Health and Human Services, who spoke during a CMS-sponsored webinar Aug. 8.

Webinar: Stage 1 of meaningful use is for quality reporting acclimation

Stage 1 requirements for meaningful use incentives aim to strike a balance between the overall goal of EHR use and widespread adoption, while avoiding added work, said Jonathan Teich, MD, PhD, chief medical informatics officer at Elsevier Health Services, during a HIMSS webinar titled “Meaningful Use: Safety and Quality of Care.”

PORTALS

Advanced Visualization

Molecular Imaging

Integration Tools & Interoperability

More Portal Topics